FLUOCINONIDE TOPICAL SOLUTION
Zydus Cadila gets USFDA nod to market 4 generic productsPharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America.
Lupin receives US FDA approval for anti-inflammatory topical solutionFluocinonide topical solution USP, 0.05% clocked sales of $32.4 million in the US, Lupin said in a release citing IMS MAT March 2017 data.
- Load More